Skip to content

pharmaceuticals.co.nz

Drugs, medicines and medical news
Main navigation

Month: March 2021

Three-layered masks most effective against large respiratory droplets

If you are going to buy a face mask to protect yourself and others from COVID-19, make sure […]

March 19, 2021 Uncategorized

Automatic adverse drug reaction extraction from EHR

The IXA group at the University of the Basque Country (UPV/EHU) is using natural language processing to extract […]

March 19, 2021 Uncategorized

Government pledges {pound}932m to cut emissions from hospitals and other public buildings

More than 400 projects across England will receive funding totalling £932m (€1.1bn; £1.3bn) to reduce carbon emissions from […]

March 19, 2021 Uncategorized

Covid-19: Eight in 10 Wuhan residents with antibodies had no symptoms, finds study

More than three quarters of Wuhan residents who tested positive for SARS-CoV-2 antibodies had experienced no covid-19 symptoms […]

March 19, 2021 COVID-19

Failure to achieve global vaccine equity will have dire consequences

I appreciate Hurley’s call for internationally equitable vaccination, which makes a clear case on the grounds of both […]

March 19, 2021 COVID-19

Disability in children and adolescents must be integrated into the global health agenda

The title of this analysis by Alarcos Cieza and colleagues (BMJ 2021;372:n9, doi:10.1136/bmj.n9) has been amended at the request of […]

March 19, 2021 Uncategorized

Covid-19: AstraZeneca vaccine is not linked to increased risk of blood clots, finds European Medicine Agency

The Oxford-AstraZeneca covid-19 vaccine is not linked to an increased risk of blood clots and is both safe […]

March 19, 2021 COVID-19

Havas Lynx and Syneos take home most agency Golds at PM Society awards

On the client side, AstraZeneca came out on top with four Golds, one Silver and one Bronze awards

March 19, 2021 Uncategorized

EU authorisation for XPhyto’s rapid COVID-19 PCR test

PCR-based test has a sample collection to result time of 25 minutes

March 19, 2021 Uncategorized

ICR’s ‘resistance-busting’ drug advances into Phase I trial

EP0042 is a dual-inhibitor drug designed to block the activity of two cancer-driving proteins

March 19, 2021 Uncategorized

Posts navigation

Posts pagination

« Previous 1 … 19 20 21 … 52 Next »
Proudly powered by WordPress | Theme: Hive Lite by Pixelgrade.
Footer navigation
  • Privacy Policy